AGP Picks
View all

AGP Executive Report

Last update: 9 hours ago

Medicines and Trade: Liechtenstein and its EFTA partners signed a free-trade agreement with Vietnam, which exports seafood, textiles and electronics to EFTA and imports products including pharmaceuticals. The pact sets out broad trade rules; no specific change to medicine access was reported. Cancer Treatment: The European Medicines Agency’s medicines committee recommended daraxonrasib for some adults with metastatic pancreatic cancer after prior treatment. European Commission approval is still pending.

Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.

AGP Wire

fallback image
Sep. 7, 2026

Swiss parabolic flight campaign pivots toward commercial space applications

AGP

fallback image
Jul. 3, 2026

European Commission authorizes CinnaGen’s osteoporosis biosimilar Zandoriah in EU

AGP

fallback image
Jul. 28, 2026

The European releases its Summer 2026 edition

AGP

fallback image
Jul. 2, 2026

American Swiss Foundation honors Adrian Keller at leadership dinner in Rüschlikon

AGP


Perspectify logo Perspectify News

Learn about labels.

Labels
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate Press Release Service
filter

Filter

Source Label Filters

All labels are selected. Deselect any labels you want to hide from your feed.

Labels:

Left-wing
Center-left
Neutral
Public Broadcaster
Gov't Institution
Center-right
Right-wing
Pro-Government
Gov't Propaganda
Indeterminate
Press Release Service

fallback image
Oct. 15, 2026

Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer

GlobeNewswire, Inc.

fallback image
Sep. 25, 2026

European Commission grants marketing authorisation for NEZGLYAL® (leriglitazone), the first pharmacological treatment approved for cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease

GlobeNewswire, Inc.

fallback image
Sep. 18, 2026

Zealand Pharma receives positive CHMP opinion for Zeydovio™ (glepaglutide) for the treatment of short bowel syndrome

GlobeNewswire, Inc.

fallback image
Jul. 23, 2026

Healthcare Holding Switzerland Secures CHF 80 Million Syndicated Financing

GlobeNewswire, Inc.

fallback image
Jul. 24, 2026

NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)

GlobeNewswire, Inc.

fallback image
Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

GlobeNewswire, Inc.

More press releases

Video Stories

YouTube video thumbnail: Liechtenstein: Europe’s Last Absolute Monarchy
Play
Liechtenstein: Europe’s Last Absolute Monarchy
YouTube video thumbnail: Geography Now! Liechtenstein
Play
Geography Now! Liechtenstein
Affinity Group Publishing Logo Showcase
Discover Affinity Group Publishing
YouTube video thumbnail: How an Isolated Valley Became the World's Richest Country
Play
How an Isolated Valley Became the World's Richest Country
YouTube video thumbnail: What Happened with Liechtenstein in WW2?
Play
What Happened with Liechtenstein in WW2?

Video Title

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

globe

Explore More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Monitor Liechtenstein

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.